Q1 2023 revenues grew 618% year-over-year to $5.7 million Q1 2023 gross margin grew to 41.9% from 31.5% in prior quarter Gross profit of $2.4 million, an increase of $1.1 million from prior quarter Ended quarter with cash position of $26.4 million All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 16, 2023 /PRNewswire/ – Numinus Wellness Inc.


Previous articleInsuring Psychedelics: The Missing Link
Next articleRevive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19